These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Faghih R; Gfesser GA; Gopalakrishnan M Recent Pat CNS Drug Discov; 2007 Jun; 2(2):99-106. PubMed ID: 18221220 [TBL] [Abstract][Full Text] [Related]
3. The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets? Thomsen MS; Mikkelsen JD Curr Drug Targets; 2012 May; 13(5):707-20. PubMed ID: 22300038 [TBL] [Abstract][Full Text] [Related]
4. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations. Williams DK; Wang J; Papke RL Biochem Pharmacol; 2011 Oct; 82(8):915-30. PubMed ID: 21575610 [TBL] [Abstract][Full Text] [Related]
5. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein. Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730 [TBL] [Abstract][Full Text] [Related]
6. An Evolving Therapeutic Rationale for Targeting the α Deutsch SI; Burket JA Curr Top Behav Neurosci; 2020; 45():167-208. PubMed ID: 32468495 [TBL] [Abstract][Full Text] [Related]
7. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively. Giraudo A; Pallavicini M; Bolchi C Pharmacol Res; 2023 Jul; 193():106801. PubMed ID: 37236412 [TBL] [Abstract][Full Text] [Related]
8. The α7 nAChR selective agonists as drug candidates for Alzheimer's disease. Fan H; Gu R; Wei D Adv Exp Med Biol; 2015; 827():353-65. PubMed ID: 25387975 [TBL] [Abstract][Full Text] [Related]
9. Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain. Toyohara J; Wu J; Hashimoto K Curr Top Med Chem; 2010; 10(15):1544-57. PubMed ID: 20583992 [TBL] [Abstract][Full Text] [Related]
10. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions. Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149 [TBL] [Abstract][Full Text] [Related]
11. α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia. Ishikawa M; Hashimoto K Curr Pharm Des; 2011; 17(2):121-9. PubMed ID: 21355839 [TBL] [Abstract][Full Text] [Related]
12. Selective activation of α7 nicotinic acetylcholine receptors augments hippocampal oscillations. Stoiljkovic M; Kelley C; Nagy D; Leventhal L; Hajós M Neuropharmacology; 2016 Nov; 110(Pt A):102-108. PubMed ID: 27422408 [TBL] [Abstract][Full Text] [Related]
13. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor. Xiao Y; Hammond PS; Mazurov AA; Yohannes D J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444 [TBL] [Abstract][Full Text] [Related]
14. Methyllycaconitine: a non-radiolabeled ligand for mapping α7 neuronal nicotinic acetylcholine receptors - in vivo target localization and biodistribution in rat brain. Nirogi R; Kandikere V; Bhyrapuneni G; Saralaya R; Muddana N; Komarneni P J Pharmacol Toxicol Methods; 2012 Jul; 66(1):22-8. PubMed ID: 22609758 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of Papke RL; Horenstein NA Pharmacol Rev; 2021 Jul; 73(3):1118-1149. PubMed ID: 34301823 [TBL] [Abstract][Full Text] [Related]
16. Activators of α7 nAChR as Potential Therapeutics for Cognitive Impairment. Wang X; Bell IM; Uslaner JM Curr Top Behav Neurosci; 2020; 45():209-245. PubMed ID: 32451955 [TBL] [Abstract][Full Text] [Related]